Literature DB >> 19913469

Vascularised fibula grafts for early tibia reconstruction in infants with congenital pseudarthrosis.

Dominique Erni1, Sora De Kerviler, Ralph Hertel, Theddy Slongo.   

Abstract

Congenital pseudarthrosis of the tibia (CPT) is caused by an ill-defined, segmental disturbance of periosteal bone formation leading to spontaneous bowing, followed by fracture and subsequent pseudarthrosis in the first 2 years of life. The results of conventional treatment modalities (e.g., bracing, internal and external fixation and bone grafting) are associated with high failure rates in terms of persisting pseudarthrosis, malunion and impaired growth. As a more promising alternative, a more aggressive approach, including wide resection of the affected bone, reconstruction with free vascularised fibula grafts from the healthy contralateral leg and stable external fixation at a very early stage has been suggested. Between 1995 and 2007, 10 children (age 12-31 months, median 20 months) suffering from CPT were treated at our institutions according to this principle. Two patients were treated before a fracture had occurred. The length of the fibula graft was 7-9cm. End-to-end anastomoses were performed at the level of the distal tibia stump. The follow-up was 80 months (median, range 12 months to 12 years). Radiologic examination at 6 weeks postoperatively showed normal bone density and structure of the transplanted fibula in all cases and osseous consolidation at 19 of the 20 graft/tibia junctions. One nonunion was sucessfully treated with bone grafting and plate osteosynthesis. Pin-tract infection occurred in three patients. Five children sustained graft fractures that were successfully treated with internal or external fixation. Two patients developed diminished growth of the affected limb or foot; all others had equal limb length and shoe size. At long-term follow-up, tibialisation of the transplant had occurred, and normal gait and physical activities were possible in all children. We conclude that in spite of a relatively high complication rate and the reluctance to perform free flap surgery in infants at this young age, the present concept may successfully prevent the imminent severe sequelae associated with CPT. Copyright 2009 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19913469     DOI: 10.1016/j.bjps.2009.09.016

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  5 in total

Review 1.  Vascularized fibular grafts for the treatment of long bone defects: pros and cons. A systematic review and meta-analysis.

Authors:  Christian Candrian; Giuseppe Filardo; Pietro Feltri; Luca Solaro; Costantino Errani; Guglielmo Schiavon
Journal:  Arch Orthop Trauma Surg       Date:  2021-06-10       Impact factor: 3.067

2.  Early Vascularized Fibular Grafts in Infants with Congenital Pseudarthrosis.

Authors:  Ki Ho Kim; Seungki Youn; Tai Seung Kim; Heechang Ahn
Journal:  Arch Plast Surg       Date:  2016-11-18

3.  Wrapping grafting for congenital pseudarthrosis of the tibia: A preliminary report.

Authors:  An Yan; Hai-Bo Mei; Kun Liu; Jiang-Yan Wu; Jin Tang; Guang-Hui Zhu; Wei-Hua Ye
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

4.  Combined massive allograft and intramedullary vascularized fibula transfer: the Capanna technique for treatment of congenital pseudarthrosis of the tibia.

Authors:  Stefanie C M Van Den Heuvel; Hay A H Winters; Klaas H Ultee; Nienke Zijlstra-Koenrades; Ralph J B Sakkers
Journal:  Acta Orthop       Date:  2020-06-08       Impact factor: 3.717

5.  New insights into osteogenic and chondrogenic differentiation of human bone marrow mesenchymal stem cells and their potential clinical applications for bone regeneration in pediatric orthopaedics.

Authors:  Nicola Giuliani; Gina Lisignoli; Marina Magnani; Costantina Racano; Marina Bolzoni; Benedetta Dalla Palma; Angelica Spolzino; Cristina Manferdini; Caterina Abati; Denise Toscani; Andrea Facchini; Franco Aversa
Journal:  Stem Cells Int       Date:  2013-05-23       Impact factor: 5.443

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.